Non-small Cell Lung Cancer (Adenocarcinoma) (DBCOND0084398)

Identifiers

Synonyms

Non-small Cell Lung Cancer Adenocarcinoma

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT03696212	Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma	Grapiprant Pembrolizumab	treatment	1 / 2	terminated